• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝内胆管癌死亡率的上升是否反映了真正的风险增加?来自苏格兰癌症登记数据的见解。

Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland.

作者信息

Wood R, Brewster D H, Fraser L A, Brown H, Hayes P C, Garden O J

机构信息

Information and Statistics Division of NHSScotland, Trinity Park House, South Trinity Road, Edinburgh EH5 3SQ, UK.

出版信息

Eur J Cancer. 2003 Sep;39(14):2087-92. doi: 10.1016/s0959-8049(03)00544-6.

DOI:10.1016/s0959-8049(03)00544-6
PMID:12957464
Abstract

The mortality from intrahepatic cholangiocarcinoma has increased recently in England and Wales and elsewhere. This study aims to examine recent trends in the incidence of intrahepatic cholangiocarcinoma in Scotland, to assess the extent to which changes in diagnostic practice may be influencing the observed trends, and to consider whether the results are compatible with a genuine increase in the risk of this cancer. Cancer registration (intrahepatic cholangiocarcinoma and anatomically adjacent cancers) data from Scotland 1968-1997 were analysed, including examination of trends in the percentage of cases recorded as being microscopically-verified. Since the late 1960s, the incidence of intrahepatic cholangiocarcinoma has increased approximately eight-fold in both sexes in Scotland. However, the proportion of cases verified microscopically has decreased substantially since the late 1970s, presumably due to an increasing reliance on radiological imaging for diagnosis. Despite this change in diagnostic practice, the incidence of microscopically-verified intrahepatic cholangiocarcinoma has also increased. While changes in diagnostic practice and misclassification could explain, at least part of, the observed increase in incidence of intrahepatic cholangiocarcinoma, a genuine increase in the risk of this cancer in the Scottish population seems probable. Further work is indicated to examine international trends in incidence, and to assess whether incidence differs within countries according to characteristics such as area of residence, socio-economic status, ethnic origin or occupation.

摘要

近期,英格兰、威尔士及其他地区肝内胆管癌的死亡率有所上升。本研究旨在调查苏格兰肝内胆管癌发病率的近期趋势,评估诊断实践的变化对所观察到的趋势的影响程度,并探讨这些结果是否与该癌症风险的真正增加相符。分析了1968年至1997年苏格兰癌症登记(肝内胆管癌及解剖学上相邻的癌症)数据,包括对记录为经显微镜确诊的病例百分比趋势的检查。自20世纪60年代末以来,苏格兰男女肝内胆管癌的发病率均增加了约八倍。然而,自20世纪70年代末以来,经显微镜确诊的病例比例大幅下降,这可能是由于越来越依赖放射影像学进行诊断。尽管诊断实践发生了这种变化,但经显微镜确诊的肝内胆管癌的发病率也有所上升。虽然诊断实践的变化和错误分类至少可以部分解释所观察到的肝内胆管癌发病率的增加,但苏格兰人群中这种癌症风险的真正增加似乎是可能的。需要进一步开展工作,以研究发病率的国际趋势,并评估发病率在各国是否因居住地区、社会经济地位、种族或职业等特征而有所不同。

相似文献

1
Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland.肝内胆管癌死亡率的上升是否反映了真正的风险增加?来自苏格兰癌症登记数据的见解。
Eur J Cancer. 2003 Sep;39(14):2087-92. doi: 10.1016/s0959-8049(03)00544-6.
2
Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?胆管癌发病率上升趋势:国际疾病分类系统是否在误导我们?
J Hepatol. 2012 Apr;56(4):848-54. doi: 10.1016/j.jhep.2011.11.015. Epub 2011 Dec 13.
3
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.1968年至1998年英格兰和威尔士肝内胆管癌死亡率的上升。
Gut. 2001 Jun;48(6):816-20. doi: 10.1136/gut.48.6.816.
4
Cholangiocarcinoma in Germany: Epidemiologic trends and impact of misclassification.德国胆管癌:流行病学趋势和分类错误的影响。
Liver Int. 2019 Feb;39(2):316-323. doi: 10.1111/liv.13954. Epub 2018 Oct 8.
5
Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.全球肝内和肝外胆管癌死亡率的趋势。
J Hepatol. 2019 Jul;71(1):104-114. doi: 10.1016/j.jhep.2019.03.013. Epub 2019 Mar 23.
6
Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.美国原发性肝内胆管癌的发病率和死亡率不断上升。
Hepatology. 2001 Jun;33(6):1353-7. doi: 10.1053/jhep.2001.25087.
7
Descriptive epidemiology of cholangiocarcinoma in Italy.意大利胆管癌的描述性流行病学。
Dig Liver Dis. 2010 Jul;42(7):490-5. doi: 10.1016/j.dld.2009.10.009. Epub 2009 Dec 22.
8
Long-term trends in incidence and mortality of intrahepatic and extrahepatic bile duct cancer in Japan.日本肝内和肝外胆管癌的发病率和死亡率的长期趋势。
J Epidemiol. 2014;24(3):193-9. doi: 10.2188/jea.je20130122. Epub 2014 Mar 7.
9
Epidemiology of intrahepatic, perihilar, and distal cholangiocarcinoma in the French population.法国人群肝内、肝门周围及肝外胆管癌的流行病学
Eur J Gastroenterol Hepatol. 2019 Jun;31(6):678-684. doi: 10.1097/MEG.0000000000001337.
10
Epidemiology of cancer of the liver and intrahepatic bile ducts in an Australian population.澳大利亚人群中肝癌和肝内胆管癌的流行病学
Asian Pac J Cancer Prev. 2010;11(6):1479-85.

引用本文的文献

1
Development and Validation of a Radiomic-Based Model for Prediction of Intrahepatic Cholangiocarcinoma in Patients With Intrahepatic Lithiasis Complicated by Imagologically Diagnosed Mass.基于影像组学的模型在预测肝内结石合并影像学诊断肿块患者肝内胆管癌中的开发与验证
Front Oncol. 2021 Jan 7;10:598253. doi: 10.3389/fonc.2020.598253. eCollection 2020.
2
MRPL27 contributes to unfavorable overall survival and disease-free survival from cholangiocarcinoma patients.MRPL27 与胆管癌患者的总生存和无病生存不良相关。
Int J Med Sci. 2021 Jan 1;18(4):936-943. doi: 10.7150/ijms.50782. eCollection 2021.
3
A novel nomogram for the prediction of intrahepatic cholangiocarcinoma in patients with intrahepatic lithiasis complicated by imagiologically diagnosed mass.
一种用于预测肝内结石合并影像学诊断肿块患者肝内胆管癌的新型列线图。
Cancer Manag Res. 2018 Apr 23;10:847-856. doi: 10.2147/CMAR.S157506. eCollection 2018.
4
Cholangiocarcinoma: increasing burden of classifications.胆管癌:分类负担日益加重。
Hepatobiliary Surg Nutr. 2013 Oct;2(5):272-80. doi: 10.3978/j.issn.2304-3881.2013.10.02.
5
Smoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma: a meta-analysis.吸烟、饮酒与肝外胆管癌风险:荟萃分析。
World J Gastroenterol. 2013 Dec 14;19(46):8780-8. doi: 10.3748/wjg.v19.i46.8780.
6
Intra-hepatic cholangiocarcinoma--frequency and demographic patterns: thirty-year data from the M.D. Anderson Cancer Center.肝内胆管细胞癌——频率和人口统计学模式:来自 M.D. 安德森癌症中心的三十年数据。
J Cancer Res Clin Oncol. 2011 Jul;137(7):1071-8. doi: 10.1007/s00432-010-0971-z. Epub 2011 Jan 5.
7
Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors.肝内和肝外胆管癌:流行病学和危险因素的新见解。
World J Gastrointest Oncol. 2010 Nov 15;2(11):407-16. doi: 10.4251/wjgo.v2.i11.407.
8
Current status of intrahepatic cholangiocarcinoma.肝内胆管癌的现状
World J Gastroenterol. 2008 Nov 7;14(41):6289-97. doi: 10.3748/wjg.14.6289.
9
Liver resection for intrahepatic cholangiocellular carcinoma: when is it worthwhile?肝内胆管细胞癌的肝切除术:何时值得进行?
World J Surg. 2008 Dec;32(12):2681-2. doi: 10.1007/s00268-008-9730-6.
10
Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma.肝内胆管癌的手术结果及预后因素
World J Surg. 2008 Dec;32(12):2675-80. doi: 10.1007/s00268-008-9778-3.